Alejandro Sanchez, MD
Urology · Boston, MANPI 1760777429
Payments from drug & device makers
What this record shows
This record is dominated by education: $4,000 of the $6,432 with a category attached, or 62.2%. Intuitive Surgical accounts for 98.4% of it on its own, with 1 other manufacturer making up the rest. 2025 is the largest year on record at $6,329, more than ten times the $100 reported in 2022.
Across 15 payments — averaging $428.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Janssen Research & Development, LLC$100
Across 38 payments — averaging $9026.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- QED Therapeutics, Inc.$188K
- Genentech, Inc.$117K
- Janssen Research & Development, LLC$31K
- Telix Pharmaceuticals$7K
What the payments were for
- Travel & lodging$2,29536%
- Food & beverage$1362%
- Education$4,00062%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 13 | $6,332 |
| Janssen Research & Development, LLC | 2 | $100 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DA VINCI SP$4,000
- Da Vinci Surgical System$2,238
How this compares
$6,432 in reported general payments places this provider in the 75th percentile of 327 urology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Finasteride | 47 | $631 |
| Tamsulosin Hcl | 32 | $286 |
Paid to pharmacies, not to this prescriber.
Other urology in Boston
- Christopher CutieBoston$3.5M
- Brian EisnerBoston$424K
- Stephen DretlerBoston$298K
- Tony LuongoBoston$265K
- Ricardo MunarrizBoston$118K
- Mehrdad AlemozaffarBoston$95K
- Adam KibelBoston$92K
- Ruslan KoretsBoston$86K
- Adam FeldmanBoston$74K
- William BoysenBoston$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.